Shared Risk Factors in Cardiovascular Disease and Cancer
暂无分享,去创建一个
A. Blaes | Anna E. Prizment | R. Koene | A. Prizment | S. Konety | Ryan J. Koene | Anne Blaes | Suma H. Konety | Suma H Konety | Ryan J Koene
[1] Thomas R Frieden,et al. CDC Health Disparities and Inequalities Report - United States, 2013. Foreword. , 2013, MMWR supplements.
[2] Jennifer G. Robinson,et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[3] S. Costanzo,et al. Contemporary Reviews in Cardiovascular Medicine Cardiovascular and Overall Mortality Risk in Relation to Alcohol Consumption in Patients With Cardiovascular Disease , 2010 .
[4] J. Myers,et al. Exercise and Cardiovascular Health , 2003 .
[5] D. Balzi,et al. Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients , 2010, Diabetes Care.
[6] D. Hayes,et al. Heart of darkness: the downside of trastuzumab. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Anette Hjartåker,et al. Body mass index, physical activity, and colorectal cancer by anatomical subsites: a systematic review and meta-analysis of cohort studies , 2013, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[8] Tamra E. Meyer,et al. Non-Steroidal Anti-Inflammatory Drugs Use Is Associated with Reduced Risk of Inflammation-Associated Cancers: NIH-AARP Study , 2014, PloS one.
[9] Laura J Rasmussen-Torvik,et al. Ideal Cardiovascular Health Is Inversely Associated With Incident Cancer: The Atherosclerosis Risk in Communities Study , 2013, Circulation.
[10] Z. Bloomgarden,et al. Inflammation and insulin resistance. , 2003, Diabetes care.
[11] M. Stampfer,et al. Mounting evidence for prediagnostic use of statins in reducing risk of lethal prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[13] D. de Freitas,et al. [Alcohol and cancer]. , 1997, Acta medica portuguesa.
[14] H. Seo,et al. Effects of Vitamin Treatment or Supplements with Purported Antioxidant Properties on Skin Cancer Prevention: A Meta-Analysis of Randomized Controlled Trials , 2011, Dermatology.
[15] Richard J. Johnson,et al. The immunological basis of hypertension. , 2014, American journal of hypertension.
[16] R. Marfella,et al. Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress , 2002, Circulation.
[17] Peter Libby,et al. Inflammation and cardiovascular disease mechanisms. , 2006, The American journal of clinical nutrition.
[18] L. Hemkens,et al. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study , 2009, Diabetologia.
[19] S. Lipshultz,et al. Treatment-related cardiotoxicity in survivors of childhood cancer , 2013, Nature Reviews Clinical Oncology.
[20] P. Stattin,et al. Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer Project , 2012, Hypertension.
[21] M. Dobbins,et al. The Association between Obesity and Cancer Risk: A Meta-Analysis of Observational Studies from 1985 to 2011 , 2013, ISRN preventive medicine.
[22] Raúl Baena Ruiz,et al. Diet and cancer: risk factors and epidemiological evidence. , 2014, Maturitas.
[23] U. Nöthlings,et al. Lifestyle factors and mortality among adults with diabetes: findings from the European Prospective Investigation into Cancer and Nutrition–Potsdam study * , 2010, Journal of diabetes.
[24] M. Zwahlen,et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.
[25] B. Aggarwal,et al. Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe , 2009, Clinical Cancer Research.
[26] D. Mozaffarian,et al. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.
[27] P. Ridker. Novel risk factors and markers for coronary disease. , 2000, Advances in internal medicine.
[28] Tao Wang,et al. Advances in Research on cis-9, trans-11 Conjugated Linoleic Acid: A Major Functional Conjugated Linoleic Acid Isomer , 2015, Critical reviews in food science and nutrition.
[29] D. Prows,et al. Mucin apoprotein expression in COPD. , 2002, Chest.
[30] P. Katzmarzyk,et al. Cardiovascular health metrics and accelerometer-measured physical activity levels: National Health and Nutrition Examination Survey, 2003-2006. , 2014, Mayo Clinic proceedings.
[31] Peter Boyle,et al. Tobacco smoking and cancer: A meta‐analysis , 2008, International journal of cancer.
[32] F. Hu,et al. Type 2 diabetes and risk of cancer , 2015, BMJ : British Medical Journal.
[33] A. Algra,et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials , 2010, The Lancet.
[34] S. Bernard,et al. Adipocyte Triglyceride Turnover Is Independently Associated With Atherogenic Dyslipidemia , 2012, Journal of the American Heart Association.
[35] Kevin C Oeffinger,et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] I. Astsaturov,et al. Molecular Pathways Molecular Pathways : Sterols and Receptor Signaling in Cancer , 2013 .
[37] Raynoo Thanan,et al. Oxidative Stress and Its Significant Roles in Neurodegenerative Diseases and Cancer , 2014, International journal of molecular sciences.
[38] S. Wacholder,et al. Risk of renal cell cancer in relation to diuretics, antihypertensive drugs, and hypertension. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[39] C. Friedenreich,et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.
[40] Dongfeng Zhang,et al. Physical activity and risk of breast cancer: a meta-analysis of prospective studies , 2013, Breast Cancer Research and Treatment.
[41] Dl Hoyert,et al. National Vital Statistics Reports NCHS.pdf , 2012 .
[42] M. Drazner. Contemporary Reviews in Cardiovascular Medicine The Progression of Hypertensive Heart Disease , 2011 .
[43] S. J. Henley,et al. Invasive Cancer Incidence — United States, 2010 , 2014, Morbidity and Mortality Weekly Report.
[44] R. Rosenfeld. Patients , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[45] S. Grundy. Obesity, metabolic syndrome, and coronary atherosclerosis. , 2002, Circulation.
[46] T. Lehtimäki,et al. Ideal Cardiovascular Health in Childhood and Cardiometabolic Outcomes in Adulthood: The Cardiovascular Risk in Young Finns Study , 2012, Circulation.
[47] Jiaquan Xu,et al. Deaths: preliminary data for 2011. , 2012 .
[48] C. Hudis,et al. Trastuzumab-related cardiotoxicity following anthracycline-based adjuvant chemotherapy: how worried should we be? , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] M. Leitzmann,et al. A systematic review and meta-analysis of physical activity and endometrial cancer risk , 2015, European Journal of Epidemiology.
[50] H. Adami,et al. International renal‐cell cancer study. VIII. Role of diuretics, other anti‐hypertensive medications and hypertension , 1995, International journal of cancer.
[51] G. Lip,et al. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. , 2003, American journal of hypertension.
[52] J. Ioannidis,et al. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies , 2015, BMJ : British Medical Journal.
[53] B. Peleteiro,et al. Dietary patterns and colorectal cancer: systematic review and meta-analysis , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[54] W. Lijinsky,et al. Pathologic Effects of Chronic Administration of Hydrochlorothiazide, with and without Sodium Nitrite, to F344 Rats , 1987, Toxicology and industrial health.
[55] I. Pernicova,et al. Metformin—mode of action and clinical implications for diabetes and cancer , 2014, Nature Reviews Endocrinology.
[56] G. Armstrong,et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[57] B. Reddy. Diet and excretion of bile acids. , 1981, Cancer research.
[58] Hongbing Shen,et al. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies , 2009, European Journal of Human Genetics.
[59] C. Friedenreich,et al. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. , 2002, The Journal of nutrition.
[60] J. Bucher. Toxicology and Carcinogenesis Studies of Furosemide (CAS No. 54-31-9) in F344/N Rats and B6C3F1 Mice (Feed Studies). , 1989, National Toxicology Program technical report series.
[61] N. Benowitz,et al. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. , 2015, Journal of the American College of Cardiology.
[62] J. Neaton,et al. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.
[63] Matthias Egger,et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.
[64] T. Tseng,et al. Promotion of colon carcinogenesis through increasing lipid peroxidation induced in rats by a high cholesterol diet. , 1996, Cancer letters.
[65] D. Hu,et al. [Rethinking, comment and query of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults]. , 2014, Zhonghua xin xue guan bing za zhi.
[66] U. Goldbourt,et al. Does diuretic therapy increase the risk of renal cell carcinoma? , 1999, The American journal of cardiology.
[67] A. Avgerinos,et al. Serum lipids and lipoprotein disorders in cancer patients , 1987, Cancer.
[68] S. Litwin. Cardiac remodeling in obesity: time for a new paradigm. , 2010, JACC. Cardiovascular imaging.
[69] F. Islami,et al. A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. , 2014, European urology.
[70] R. Cohen,et al. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. , 1992, The American journal of physiology.
[71] U. Goldbourt,et al. Is there an association between hypertension and cancer mortality? , 2002, The American journal of medicine.
[72] C. la Vecchia,et al. Light alcohol drinking and cancer: a meta-analysis. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[73] Ridker Pm. Novel risk factors and markers for coronary disease. , 2000 .
[74] R. Alexander. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. , 1995, Hypertension.
[75] M. Stampfer,et al. Partnerships for promoting prevention. , 2013, Circulation.
[76] R. Lau,et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies , 2011, BMJ : British Medical Journal.
[77] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[78] D. Reid,et al. Patterns of dietary intake and serum carotenoid and tocopherol status are associated with biomarkers of chronic low-grade systemic inflammation and cardiovascular risk , 2014, British Journal of Nutrition.
[79] Robert J Glynn,et al. Alcohol Consumption and Plasma Concentration of C-Reactive Protein , 2003, Circulation.
[80] Jeff S. Jasper,et al. 27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology , 2013, Science.
[81] R. Burger,et al. Use of a dummy (pacifier) during sleep and risk of sudden infant death syndrome (SIDS): population based case-control study , 2005, BMJ : British Medical Journal.
[82] W. Ghali,et al. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis , 2011, BMJ : British Medical Journal.
[83] A. Chan,et al. Aspirin for the prevention of colorectal cancer. , 2011, Best practice & research. Clinical gastroenterology.
[84] C. Gross,et al. Risk Prediction Model for Heart Failure and Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer , 2014, Journal of the American Heart Association.
[85] Napoleone Ferrara,et al. VEGF and the quest for tumour angiogenesis factors , 2002, Nature Reviews Cancer.
[86] B. Carstensen,et al. Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence , 2012, Diabetologia.
[87] D. Cha,et al. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. , 2006, Journal of molecular endocrinology.
[88] D. English,et al. Red meat, chicken, and fish consumption and risk of colorectal cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[89] R. Shephard. Body-Mass Index and Mortality among 1.46 Million White Adults , 2011 .
[90] G. Colditz,et al. Obesity and Cancer , 2010, The oncologist.
[91] C Michael White,et al. Statins and Cancer Risk: A Meta-analysis , 2007 .
[92] J. Dixon,et al. Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[93] Edward Giovannucci,et al. Diabetes and Cancer , 2010, Diabetes Care.
[94] C. Whitney,et al. Non-pneumococcal mitis-group streptococci confound detection of pneumococcal capsular serotype-specific loci in upper respiratory tract , 2013, PeerJ.
[95] P. Ganz,et al. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort , 2011, Breast Cancer Research and Treatment.
[96] U. Bauer,et al. [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.
[97] K Straif,et al. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. , 2004, Lung cancer.
[98] L. Aaltonen,et al. Lessons from functional analysis of genome-wide association studies. , 2013, Cancer research.
[99] G. Barrera. Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy , 2012, ISRN oncology.
[100] Z. Duan,et al. Interleukin-6 signaling pathway in targeted therapy for cancer. , 2012, Cancer treatment reviews.
[101] J. Gustafsson,et al. On estrogen, cholesterol metabolism, and breast cancer. , 2014, The New England journal of medicine.
[102] S. Weitzman,et al. Chronic inflammation and cancer: the role of the mitochondria. , 2011, Oncology.
[103] T. Choueiri,et al. Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway , 2015, Cancer.
[104] E. Murphy. Estrogen signaling and cardiovascular disease. , 2011, Circulation research.
[105] S. Bojesen,et al. Statin use and reduced cancer-related mortality. , 2012, The New England journal of medicine.
[106] A. Khera,et al. Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association , 2011, Circulation.
[107] S. Nie,et al. The dose–response effect of physical activity on cancer mortality: findings from 71 prospective cohort studies , 2015, British Journal of Sports Medicine.
[108] N. Hou,et al. Leptin and cardiovascular diseases , 2011, Clinical and experimental pharmacology & physiology.
[109] Z. Oltvai,et al. Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion , 2014, Scientific Reports.
[110] Dirk W Lachenmeier,et al. Alcohol consumption and ethyl carbamate. , 2010, IARC monographs on the evaluation of carcinogenic risks to humans.
[111] S. Zhong,et al. Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies. , 2015, Cancer treatment reviews.
[112] J. Mclaughlin,et al. Increased risk of renal cell cancer among women using diuretics in the United States , 1993, Cancer Causes & Control.
[113] P. Scherer,et al. Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.
[114] K. Sheahan,et al. Estrogen Receptors and Their Implications in Colorectal Carcinogenesis , 2015, Front. Oncol..
[115] R. Kaaks,et al. Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .